247 related articles for article (PubMed ID: 36882658)
21. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
22. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
MacDonald JK; Nguyen TM; Khanna R; Timmer A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007572. PubMed ID: 27885650
[TBL] [Abstract][Full Text] [Related]
23. Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis.
Zaman S; Akingboye A; Mohamedahmed AYY; Peterknecht E; Bhattacharya P; El-Asrag ME; Iqbal TH; Quraishi MN; Beggs AD
J Crohns Colitis; 2024 Jan; 18(1):144-161. PubMed ID: 37450947
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
Narula N; Kassam Z; Yuan Y; Colombel JF; Ponsioen C; Reinisch W; Moayyedi P
Inflamm Bowel Dis; 2017 Oct; 23(10):1702-1709. PubMed ID: 28906291
[TBL] [Abstract][Full Text] [Related]
25. Enteral nutritional therapy for induction of remission in Crohn's disease.
Narula N; Dhillon A; Zhang D; Sherlock ME; Tondeur M; Zachos M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000542. PubMed ID: 29607496
[TBL] [Abstract][Full Text] [Related]
26. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
Hui W; Li T; Liu W; Zhou C; Gao F
PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
[TBL] [Abstract][Full Text] [Related]
27. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Colman RJ; Rubin DT
J Crohns Colitis; 2014 Dec; 8(12):1569-81. PubMed ID: 25223604
[TBL] [Abstract][Full Text] [Related]
28. Enteral nutritional therapy for induction of remission in Crohn's disease.
Zachos M; Tondeur M; Griffiths AM
Cochrane Database Syst Rev; 2007 Jan; (1):CD000542. PubMed ID: 17253452
[TBL] [Abstract][Full Text] [Related]
29. Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn's disease.
Zou B; Liu S; Li X; He J; Dong C; Ruan M; Huang Z; Shu S
Front Cell Infect Microbiol; 2023; 13():1083236. PubMed ID: 36909725
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis.
Zhao HL; Chen SZ; Xu HM; Zhou YL; He J; Huang HL; Xu J; Nie YQ
J Dig Dis; 2020 Oct; 21(10):534-548. PubMed ID: 33439534
[TBL] [Abstract][Full Text] [Related]
31. Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
Zhou HY; Guo B; Lufumpa E; Li XM; Chen LH; Meng X; Li BZ
Immunol Invest; 2021 May; 50(4):323-337. PubMed ID: 32009472
[TBL] [Abstract][Full Text] [Related]
32. Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn's Disease.
Li Q; Ding X; Liu Y; Marcella C; Dai M; Zhang T; Bai J; Xiang L; Wen Q; Cui B; Zhang F
Front Pharmacol; 2021; 12():658087. PubMed ID: 34079458
[No Abstract] [Full Text] [Related]
33. Adalimumab for induction of remission in Crohn's disease.
Abbass M; Cepek J; Parker CE; Nguyen TM; MacDonald JK; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742665
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
[TBL] [Abstract][Full Text] [Related]
35. Enteral nutritional therapy for inducing remission of Crohn's disease.
Zachos M; Tondeur M; Griffiths AM
Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
[TBL] [Abstract][Full Text] [Related]
36. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
[TBL] [Abstract][Full Text] [Related]
37. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Shi Y; Dong Y; Huang W; Zhu D; Mao H; Su P
PLoS One; 2016; 11(6):e0157259. PubMed ID: 27295210
[TBL] [Abstract][Full Text] [Related]
38. Antibiotics for induction and maintenance of remission in Crohn's disease.
Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
[TBL] [Abstract][Full Text] [Related]
39. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
40. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
